Belgium – Pharmaceutical products – Leveren van een terugbetaalde vorm van Bevacizumab 100 mg/4 ml en 400 mg/ 16ml voor
UZ Leuven awarded €1.5M to AMGEN NV for Healthcare & Medical in July 2026 — one of 140 awards this buyer has made, above its typical award size.
Buying agency
UZ LeuvenWinning supplier
AMGEN NVContract description
Belgium – Pharmaceutical products – Leveren van een terugbetaalde vorm van Bevacizumab 100 mg/4 ml en 400 mg/ 16ml voor intraveneus gebruik
Related awards · UZ Leuven
140 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-208398-2025HOSPITAL LOGISTICS NV€5.7M01 Apr 2025 Professional Services
- ocds-ted-324210-2025Algeco Belgium€4.6M20 May 2025 Construction
- ocds-ted-451293-2026-6Medtronic Belgium€3.4M01 Jul 2026 Professional Services
Other wins · AMGEN NV
9 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-855127-2025Universitair Ziekenhuis Antwerpen€2.4M22 Dec 2025 Healthcare
- ocds-ted-1288-2025-1A.S.Z. Autonome Verzorgingsinstelling€1.9M02 Jan 2025 Healthcare
- ocds-ted-497706-2025-2AZ Delta vzw€1.7M30 Jul 2025 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for UZ Leuven and AMGEN NV — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back